<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec3-medicines-04-00047" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">3. Results and Discussion</div>
 <p xmlns="http://www.w3.org/1999/xhtml">The sage leaf essential oil compositions are summarized in 
  <a ref-type="table" rid="medicines-04-00047-t001" href="#medicines-04-00047-t001">Table 1</a>. The sage oils were qualitatively similar and dominated by the monoterpenoids α-thujone (17–27%), 1,8-cineole (12–27%), and camphor (13–21%), with lesser amounts of β-thujone (3.8–6.0%), camphene (3.5–5.3%), and the sesquiterpene α-humulene (3.1–4.4%). This chemical profile is similar to many sage oil descriptions previously reported [
  <a rid="B15-medicines-04-00047" ref-type="bibr" href="#B15-medicines-04-00047">15</a>,
  <a rid="B17-medicines-04-00047" ref-type="bibr" href="#B17-medicines-04-00047">17</a>,
  <a rid="B18-medicines-04-00047" ref-type="bibr" href="#B18-medicines-04-00047">18</a>,
  <a rid="B19-medicines-04-00047" ref-type="bibr" href="#B19-medicines-04-00047">19</a>,
  <a rid="B20-medicines-04-00047" ref-type="bibr" href="#B20-medicines-04-00047">20</a>,
  <a rid="B22-medicines-04-00047" ref-type="bibr" href="#B22-medicines-04-00047">22</a>,
  <a rid="B24-medicines-04-00047" ref-type="bibr" href="#B24-medicines-04-00047">24</a>,
  <a rid="B25-medicines-04-00047" ref-type="bibr" href="#B25-medicines-04-00047">25</a>,
  <a rid="B26-medicines-04-00047" ref-type="bibr" href="#B26-medicines-04-00047">26</a>,
  <a rid="B27-medicines-04-00047" ref-type="bibr" href="#B27-medicines-04-00047">27</a>,
  <a rid="B28-medicines-04-00047" ref-type="bibr" href="#B28-medicines-04-00047">28</a>,
  <a rid="B29-medicines-04-00047" ref-type="bibr" href="#B29-medicines-04-00047">29</a>,
  <a rid="B30-medicines-04-00047" ref-type="bibr" href="#B30-medicines-04-00047">30</a>,
  <a rid="B31-medicines-04-00047" ref-type="bibr" href="#B31-medicines-04-00047">31</a>,
  <a rid="B32-medicines-04-00047" ref-type="bibr" href="#B32-medicines-04-00047">32</a>,
  <a rid="B33-medicines-04-00047" ref-type="bibr" href="#B33-medicines-04-00047">33</a>,
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>,
  <a rid="B39-medicines-04-00047" ref-type="bibr" href="#B39-medicines-04-00047">39</a>,
  <a rid="B40-medicines-04-00047" ref-type="bibr" href="#B40-medicines-04-00047">40</a>,
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>,
  <a rid="B42-medicines-04-00047" ref-type="bibr" href="#B42-medicines-04-00047">42</a>,
  <a rid="B44-medicines-04-00047" ref-type="bibr" href="#B44-medicines-04-00047">44</a>,
  <a rid="B45-medicines-04-00047" ref-type="bibr" href="#B45-medicines-04-00047">45</a>,
  <a rid="B47-medicines-04-00047" ref-type="bibr" href="#B47-medicines-04-00047">47</a>,
  <a rid="B49-medicines-04-00047" ref-type="bibr" href="#B49-medicines-04-00047">49</a>,
  <a rid="B51-medicines-04-00047" ref-type="bibr" href="#B51-medicines-04-00047">51</a>,
  <a rid="B52-medicines-04-00047" ref-type="bibr" href="#B52-medicines-04-00047">52</a>,
  <a rid="B53-medicines-04-00047" ref-type="bibr" href="#B53-medicines-04-00047">53</a>,
  <a rid="B55-medicines-04-00047" ref-type="bibr" href="#B55-medicines-04-00047">55</a>,
  <a rid="B57-medicines-04-00047" ref-type="bibr" href="#B57-medicines-04-00047">57</a>,
  <a rid="B58-medicines-04-00047" ref-type="bibr" href="#B58-medicines-04-00047">58</a>,
  <a rid="B60-medicines-04-00047" ref-type="bibr" href="#B60-medicines-04-00047">60</a>,
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>,
  <a rid="B63-medicines-04-00047" ref-type="bibr" href="#B63-medicines-04-00047">63</a>,
  <a rid="B64-medicines-04-00047" ref-type="bibr" href="#B64-medicines-04-00047">64</a>,
  <a rid="B65-medicines-04-00047" ref-type="bibr" href="#B65-medicines-04-00047">65</a>,
  <a rid="B67-medicines-04-00047" ref-type="bibr" href="#B67-medicines-04-00047">67</a>], yet notably different from many others [
  <a rid="B14-medicines-04-00047" ref-type="bibr" href="#B14-medicines-04-00047">14</a>,
  <a rid="B25-medicines-04-00047" ref-type="bibr" href="#B25-medicines-04-00047">25</a>,
  <a rid="B26-medicines-04-00047" ref-type="bibr" href="#B26-medicines-04-00047">26</a>,
  <a rid="B34-medicines-04-00047" ref-type="bibr" href="#B34-medicines-04-00047">34</a>,
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>,
  <a rid="B38-medicines-04-00047" ref-type="bibr" href="#B38-medicines-04-00047">38</a>,
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>,
  <a rid="B46-medicines-04-00047" ref-type="bibr" href="#B46-medicines-04-00047">46</a>,
  <a rid="B54-medicines-04-00047" ref-type="bibr" href="#B54-medicines-04-00047">54</a>,
  <a rid="B56-medicines-04-00047" ref-type="bibr" href="#B56-medicines-04-00047">56</a>]. This prompted us to undertake a hierarchical cluster analysis of 
  <span class="italic">S. officinalis</span> leaf oil compositions in order to describe the various chemotypes of this herb.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Tucker and Maciarello described five groups based on four principal constituents: (1) camphor &gt; α-thujone &gt; 1,8-cineole &gt; β-thujone; (2) camphor &gt; α-thujone &gt; β-thujone &gt; 1,8-cineole; (3) β-thujone &gt; camphor &gt; 1,8-cineole &gt; α-thujone; (4) 1,8-cineole &gt; camphor &gt; α-thujone &gt; β-thujone; and (5) α-thujone &gt; camphor &gt; β-thujone &gt; 1,8-cineole [
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>]. Unfortunately, while these four principal constituents describe many 
  <span class="italic">S. officinalis</span> essential oils, there are other samples that are rich in α-humulene [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>,
  <a rid="B56-medicines-04-00047" ref-type="bibr" href="#B56-medicines-04-00047">56</a>], viridiflorol [
  <a rid="B26-medicines-04-00047" ref-type="bibr" href="#B26-medicines-04-00047">26</a>,
  <a rid="B34-medicines-04-00047" ref-type="bibr" href="#B34-medicines-04-00047">34</a>], manool [
  <a rid="B34-medicines-04-00047" ref-type="bibr" href="#B34-medicines-04-00047">34</a>,
  <a rid="B66-medicines-04-00047" ref-type="bibr" href="#B66-medicines-04-00047">66</a>], or sclareol [
  <a rid="B54-medicines-04-00047" ref-type="bibr" href="#B54-medicines-04-00047">54</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Jug-Dujaković and co-workers examined the essential oil compositions of 25 indigenous populations of 
  <span class="italic">S. officinalis</span> growing in the Dalmatian region of Croatia [
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>]. These workers carried out a hierarchical cluster analysis based on eight principal components (α-thujone, camphor, β-thujone, 1,8-cineole, β-pinene, camphene, borneol, and bornyl acetate), and were able to delineate three chemotypes of Dalmatian sage from Dalmatia: (A) α-thujone &gt; camphor &gt; 1,8-cineole &gt; β-thujone; (B) β-thujone &gt; α-thujone &gt; camphor ≈ 1,8-cineole; and (C) camphor &gt; α-thujone &gt; 1,8-cineole &gt; camphene ≈ borneol.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Lakušić and co-workers analyzed 
  <span class="italic">S. officinalis</span> essential oils in various stages of development [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>]. These workers sampled two different individual plants from different geographical origin, but grown in a common garden under identical conditions. Young leaves were characterized with high concentrations of α-humulene, viridiflorol, and manool, but low concentrations of camphor or α-thujone. As leaves aged, the concentrations of α-humulene, viridiflorol, and manool dropped significantly with concomitant increases in camphor and α-thujone. A hierarchical cluster analysis showed that young leaves belonged to an α-humulene chemotype, while old leaves from the plant originating in Serbia belonged to a camphor chemotype, and old leaves from the plant originating in Croatia belonged to a thujone chemotype.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">In this current work, we have carried out a hierarchical cluster analysis of 188 
  <span class="italic">S. officinalis</span> leaf essential oil compositions; the three chemical compositions presented above in conjunction with 185 analyses from the literature. A total of 26 components were used in the analysis. Based on the cluster analysis of the volatile compositions, there are five major chemotypes of 
  <span class="italic">Salvia officinalis</span>: C1–C5 (see 
  <a ref-type="fig" rid="medicines-04-00047-f001" href="#medicines-04-00047-f001">Figure 1</a>).
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The most populated chemotype, C1, is an α-thujone/camphor chemotype and represents “typical” sage oil. The C1 cluster can be further subdivided (
  <a ref-type="fig" rid="medicines-04-00047-f002" href="#medicines-04-00047-f002">Figure 2</a>) into three distinct subgroups: C1a, camphor &gt; α-thujone &gt; β-pinene, which is equivalent to group 1 described by Tucker and Maciarello [
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>], type C described by Jug-Dujaković et al. [
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>], and type IIb described by Lakušić and co-workers [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>]; C1b, α-thujone ≈ camphor &gt; sclareol; and C1c, α-thujone &gt; camphor &gt; 1,8-cineole, which is equivalent to Tucker and Maciarello type 5 [
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>], Jug-Dujaković et al. type A [
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>], and Lakušić et al. type IIa [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>]. Chemotype C1c averages 28.0% α-thujone, 18.6% camphor, 10.5% 1,8-cineole, and 6.4% β-thujone, and represents the “best overall” composition of sage oil [
  <a rid="B2-medicines-04-00047" ref-type="bibr" href="#B2-medicines-04-00047">2</a>,
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>]. It is noteworthy that type C1c is also represented by samples from the Dalmatian region of the Balkan Peninsula [
  <a rid="B26-medicines-04-00047" ref-type="bibr" href="#B26-medicines-04-00047">26</a>,
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>,
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>], as well as commercial samples from Europe [
  <a rid="B52-medicines-04-00047" ref-type="bibr" href="#B52-medicines-04-00047">52</a>] and Albania, Mexico, and California from this study.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The α-humulene-rich chemotype, C2, is equivalent to type I that was described by Lakušić and co-workers [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>]. This chemotype can be subdivided (
  <a ref-type="fig" rid="medicines-04-00047-f003" href="#medicines-04-00047-f003">Figure 3</a>) into three subgroups: C2a, α-humulene &gt; α-thujone &gt; camphor; C2b, 1,8-cineole ≈ α-thujone &gt; α-humulene; and C2c, viridiflorol &gt; manool ≈ α-thujone &gt; α-humulene. Lakušić and co-workers had observed α-humulene concentrations to be relatively high in young leaves collected in April and May, with decreasing concentrations during late summer (August–October), and then increasing again in the autumn and winter [
  <a rid="B41-medicines-04-00047" ref-type="bibr" href="#B41-medicines-04-00047">41</a>]. Samples from other global locations, however, showed high α-humulene concentrations during the summer [
  <a rid="B26-medicines-04-00047" ref-type="bibr" href="#B26-medicines-04-00047">26</a>,
  <a rid="B48-medicines-04-00047" ref-type="bibr" href="#B48-medicines-04-00047">48</a>,
  <a rid="B56-medicines-04-00047" ref-type="bibr" href="#B56-medicines-04-00047">56</a>], and likely, then, represents a real chemotype.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The β-thujone-rich chemotype, C3, is equivalent to Tucker and Maciarello type 3 [
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>] and Jug-Dujaković et al. type B [
  <a rid="B37-medicines-04-00047" ref-type="bibr" href="#B37-medicines-04-00047">37</a>]. Chemotype C3 can be subdivided into two subroups (
  <a ref-type="fig" rid="medicines-04-00047-f004" href="#medicines-04-00047-f004">Figure 4</a>): C3a, β-thujone &gt; camphor ≈ α-thujone ≈ 1,8-cineole, and C3b, camphor &gt; β-thujone &gt; 1,8-cineole. Type C4, a 1,8-cineole/camphor chemotype, is equivalent to Tucker and Maciarello type 4 [
  <a rid="B61-medicines-04-00047" ref-type="bibr" href="#B61-medicines-04-00047">61</a>], and shows two subtypes: C4a, 1,8-cineole ≈ camphor, and C4b, 1,8-cineole &gt;&gt; camphor (
  <a ref-type="fig" rid="medicines-04-00047-f005" href="#medicines-04-00047-f005">Figure 5</a>). Chemotype C5 (
  <a ref-type="fig" rid="medicines-04-00047-f006" href="#medicines-04-00047-f006">Figure 6</a>) is a sclareol/α-thujone type.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Although C1 (thujone/camphor) is the major chemotype of 
  <span class="italic">S. officinalis</span>, there are several other chemotypes and this should have a profound effect on the flavor and fragrance profile of the herb as well as any potential biological activities and medicinal uses. The overall fragrance description and the fragrance descriptions of the components of C1c type sage oils have been reported [
  <a rid="B30-medicines-04-00047" ref-type="bibr" href="#B30-medicines-04-00047">30</a>,
  <a rid="B67-medicines-04-00047" ref-type="bibr" href="#B67-medicines-04-00047">67</a>]. A perusal of the literature has not revealed any flavor or fragrance descriptions of the other sage oil chemotypes, however. Similarly, most bioactivity studies have been carried out on C1 chemotype sage oils. Savalev and co-workers have examined the butyryl- and acetyl-cholinesterase inhibitory activities of type C2a sage oils [
  <a rid="B56-medicines-04-00047" ref-type="bibr" href="#B56-medicines-04-00047">56</a>]; Lima and co-workers examined the cytotoxicity of a C2b type sage oil on rat hepatocytes [
  <a rid="B43-medicines-04-00047" ref-type="bibr" href="#B43-medicines-04-00047">43</a>]; and Abu-Darwish and co-workers carried out antifungal studies with chemotype C4b sage oils [
  <a rid="B14-medicines-04-00047" ref-type="bibr" href="#B14-medicines-04-00047">14</a>]. However, no C1c type sage oils were included in these studies for comparison. Russo and co-workers examined the cytotoxic activities on three different tumor cell lines of two different chemotypes of sage oil, C1b and C5 chemotypes, but there were no correlations between sage oil chemical compositions and cytotoxicities [
  <a rid="B54-medicines-04-00047" ref-type="bibr" href="#B54-medicines-04-00047">54</a>].
 </p>
</sec>
